Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Korea, Republic of,Taiwan, Province of China,Malaysia,Greece,Morocco,India,Germany,Belgium - Phase: complete
nct
Update Il y a 5 ans
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
The primary objective of the study is to compare, after 8 weeks, the efficacy of SR58611A vs. placebo in patients with Major Depressive Disorder who are on concomitant treatment with escitalopram. The secondary objective of this study is to document clinical safety and tolerability of SR58611A in association with escitalopram.
Country
Belgium
,
Estonia
,
Finland
,
France
,
Germany
,
Greece
,
India
,
Korea, Republic of
,
Malaysia
,
Morocco
,
Taiwan, Province of China
,
Tunisia
,
Turkey
,
organs
None
Specialty
None
Closed trial
More information
1